Alexander Henderson
Dr Alison Trainer
| A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers | 2021 |
|
Alexander Henderson
Dr Anne-Marie Gerdes
| Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study | 2021 |
|
Dr David Bourn
Professor Sir John Burn
Dr Richard Fisher
Alexander Henderson
Dr Tara Montgomery
et al. | The contribution of X-linked coding variation to severe developmental disorders | 2021 |
|
Dr David Bourn
Dr Richard Fisher
Alexander Henderson
Dr Miranda Splitt
Professor Volker Straub
et al. | Evidence for 28 genetic disorders discovered by combining healthcare and research data | 2020 |
|
Alexander Henderson
| Prostate Cancer Risk by BRCA2 Genomic Regions | 2020 |
|
Dr Paul Brennan
Professor Judith Goodship
Alexander Henderson
Linda Sneddon
| Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield | 2019 |
|
Alexander Henderson
| Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer | 2019 |
|
Alexander Henderson
| Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures | 2019 |
|
Alexander Henderson
Dr Jill Cadwgan
| Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated Care | 2019 |
|
Alexander Henderson
| Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations | 2018 |
|
Alexander Henderson
| Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition | 2018 |
|
Alexander Henderson
| PUF60 variants cause a syndrome of ID, short stature, microcephaly, coloboma, craniofacial, cardiac, renal and spinal features | 2017 |
|
Dr Anne-Marie Gerdes
Alexander Henderson
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer | 2017 |
|
Alexander Henderson
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer | 2017 |
|
Alexander Henderson
Ian Campbell
| Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores | 2017 |
|
Dr David Bourn
Professor Sir John Burn
Dr Richard Fisher
Professor Judith Goodship
Alexander Henderson
et al. | Prevalence and architecture of de novo mutations in developmental disorders | 2017 |
|
Alexander Henderson
| Clinical, Structural, Biochemical and X-Ray Crystallographic Correlates of Pathogenicity for Variants in the C-Propeptide Region of the COL3A1 Gene | 2015 |
|
Alexander Henderson
| Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum | 2014 |
|
Alexander Henderson
| Clinical evidence for a mandibular to maxillary transformation in Auriculocondylar syndrome | 2014 |
|
Dr Fiona Douglas
Alexander Henderson
Penny Wilson
| Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study | 2014 |
|
Alexander Henderson
| Heterogeneity of mutational mechanisms and modes of inheritance in auriculocondylar syndrome | 2013 |
|
Dr Fiona Douglas
Alexander Henderson
| Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer | 2013 |
|
